Chongqing Lummy Pharmaceutical Strategic Asset Allocation Index
Chongqing Lummy Pharmaceutical strategic asset allocation index. Chongqing Lummy Pharmaceutical (300006) has a Strategic Asset Allocation Index of 14.5% as of September 2023. Strategic assets (PP&E of CN¥304.16 Million plus long-term investments of CN¥-) total CN¥304.16 Million, measured against net assets of CN¥2.10 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Chongqing Lummy Pharmaceutical (300006) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Chongqing Lummy Pharmaceutical (2006–2022)
Strategic asset allocation index of Chongqing Lummy Pharmaceutical from 2006 to 2022. This chart shows how Chongqing Lummy Pharmaceutical's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2022. As of September 2023, the index stands at 14.5%, representing strategic assets of CN¥304.16 Million against net assets of CN¥2.10 Billion CNY. Check tangible equity quality of Chongqing Lummy Pharmaceutical to evaluate the tangible quality of the company's equity base.
Chongqing Lummy Pharmaceutical Strategic Asset Allocation Index by Year (2006–2022)
Chongqing Lummy Pharmaceutical strategic asset allocation index by year from 2006 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Chongqing Lummy Pharmaceutical from 2006 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Chongqing Lummy Pharmaceutical.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 15.6% | CN¥339.92 Million | CN¥339.92 Million | CN¥- | CN¥2.18 Billion | ▼ -2.2 pp |
| 2021 | 17.7% | CN¥392.49 Million | CN¥392.49 Million | CN¥- | CN¥2.21 Billion | ▼ -19.6 pp |
| 2020 | 37.3% | CN¥459.97 Million | CN¥459.97 Million | CN¥- | CN¥1.23 Billion | ▲ +1.1 pp |
| 2019 | 36.3% | CN¥600.25 Million | CN¥600.25 Million | CN¥- | CN¥1.65 Billion | ▼ -32.6 pp |
| 2018 | 68.9% | CN¥1.19 Billion | CN¥685.83 Million | CN¥502.58 Million | CN¥1.72 Billion | ▲ +5.6 pp |
| 2017 | 63.3% | CN¥1.09 Billion | CN¥781.00 Million | CN¥309.38 Million | CN¥1.72 Billion | ▲ +4.1 pp |
| 2016 | 59.1% | CN¥990.32 Million | CN¥871.33 Million | CN¥118.99 Million | CN¥1.67 Billion | ▼ -0.1 pp |
| 2015 | 59.3% | CN¥1.00 Billion | CN¥943.09 Million | CN¥58.60 Million | CN¥1.69 Billion | ▼ -37.3 pp |
| 2014 | 96.6% | CN¥981.87 Million | CN¥981.87 Million | CN¥- | CN¥1.02 Billion | ▲ +12.1 pp |
| 2013 | 84.4% | CN¥950.29 Million | CN¥950.29 Million | CN¥- | CN¥1.13 Billion | ▲ +5.1 pp |
| 2012 | 79.3% | CN¥563.64 Million | CN¥563.64 Million | CN¥- | CN¥710.51 Million | ▲ +17.2 pp |
| 2011 | 62.1% | CN¥410.17 Million | CN¥410.17 Million | CN¥- | CN¥660.17 Million | ▲ +19.6 pp |
| 2010 | 42.5% | CN¥238.88 Million | CN¥238.88 Million | CN¥- | CN¥561.59 Million | ▲ +28.8 pp |
| 2009 | 13.7% | CN¥72.03 Million | CN¥72.03 Million | CN¥- | CN¥525.08 Million | ▼ -29.7 pp |
| 2008 | 43.4% | CN¥59.76 Million | CN¥59.76 Million | CN¥- | CN¥137.79 Million | ▼ -7.7 pp |
| 2007 | 51.1% | CN¥55.14 Million | CN¥55.14 Million | CN¥- | CN¥107.91 Million | ▲ +3.6 pp |
| 2006 | 47.5% | CN¥30.56 Million | CN¥30.56 Million | CN¥- | CN¥64.39 Million | — |